Skip to main content
PMC home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1999 Jul;56(7):449–453. doi: 10.1136/oem.56.7.449

Role of individual susceptibility in risk assessment of pesticides

G Leng, J Lewalter
PMCID: PMC1757761  PMID: 10472315

Abstract

OBJECTIVES: This study presents criteria for assessing the individual pesticide burden of workers in the chemical industry. METHODS: A group of 1003 workers exposed to methylparathion or ethylparathion (alkyl phosphates), propoxur (carbamate), or cyfluthrin (pyrethroid) was investigated. After exposure to methylparathion or ethylparathion the methylparathion or ethylparathion and methylparaoxon or ethylparaoxon concentrations in plasma, the p-nitrophenol concentration in urine, and the activities of cholinesterase and acetylcholinesterase were measured. For exposure to propoxur the propoxur concentration in plasma, the 2-isopropoxyphenol concentration in urine, and the cholinesterase and acetylcholinesterase activities were measured. For exposure to cyfluthrin the cyfluthrin concentration in plasma was measured. RESULTS: At the same propoxur concentration only workers with a low individual acetylcholinesterase activity reported symptoms. Workers who metabolised cyfluthrin rapidly reported less symptoms than workers with a lower rate of metabolism. This tendency was also evident in cases of mixed exposure (cyfluthrin and methylparathion). CONCLUSIONS: In the assessment of exposure to pesticides susceptibility of the individual person has to be considered.

 

Full Text

The Full Text of this article is available as a PDF (103.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelson P. H. Exaggerated risks of chemicals. J Clin Epidemiol. 1995 Feb;48(2):173–178. doi: 10.1016/0895-4356(94)00116-8. [DOI] [PubMed] [Google Scholar]
  2. Aitio A. Biological monitoring today and tomorrow. Scand J Work Environ Health. 1994;20(Spec No):46–58. [PubMed] [Google Scholar]
  3. Aldridge W. N. An assessment of the toxicological properties of pyrethroids and their neurotoxicity. Crit Rev Toxicol. 1990;21(2):89–104. doi: 10.3109/10408449009089874. [DOI] [PubMed] [Google Scholar]
  4. Calabrese E. J. Ecogenetics: historical foundation and current status. J Occup Med. 1986 Oct;28(10):1096–1102. doi: 10.1097/00043764-198610000-00034. [DOI] [PubMed] [Google Scholar]
  5. Hoet P., Haufroid V. Biological monitoring: state of the art. Occup Environ Med. 1997 Jun;54(6):361–366. doi: 10.1136/oem.54.6.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Idle J. R., Armstrong M., Boddy A. V., Boustead C., Cholerton S., Cooper J., Daly A. K., Ellis J., Gregory W., Hadidi H. The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics. 1992 Dec;2(6):246–258. doi: 10.1097/00008571-199212000-00002. [DOI] [PubMed] [Google Scholar]
  7. KALOW W., STARON N. On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers. Can J Biochem Physiol. 1957 Dec;35(12):1305–1320. [PubMed] [Google Scholar]
  8. Kolmodin-Hedman B., Akerblom M., Flato S., Alex G. Symptoms in forestry workers handling conifer plants treated with permethrin. Bull Environ Contam Toxicol. 1995 Oct;55(4):487–493. doi: 10.1007/BF00196026. [DOI] [PubMed] [Google Scholar]
  9. Leng G., Kühn K. H., Idel H. Biological monitoring of pyrethroid metabolites in urine of pest control operators. Toxicol Lett. 1996 Nov;88(1-3):215–220. doi: 10.1016/0378-4274(96)03740-x. [DOI] [PubMed] [Google Scholar]
  10. Leng G., Kühn K. H., Idel H. Biological monitoring of pyrethroids in blood and pyrethroid metabolites in urine: applications and limitations. Sci Total Environ. 1997 Jun 20;199(1-2):173–181. doi: 10.1016/s0048-9697(97)05493-4. [DOI] [PubMed] [Google Scholar]
  11. Lewalter J., Korallus U. Erythrocyte protein conjugates as a principle of biological monitoring for pesticides. Toxicol Lett. 1986 Oct;33(1-3):153–165. doi: 10.1016/0378-4274(86)90079-2. [DOI] [PubMed] [Google Scholar]
  12. Roots I. Genetische Ursachen für die Variabilität der Wirkungen und Nebenwirkungen von Arzneimitteln. Internist (Berl) 1982 Nov;23(11):601–609. [PubMed] [Google Scholar]
  13. Schaller K. H., Angerer J., Lehnert G. Current status of the external quality assurance programmes of the German Society for Occupational and Environmental Medicine. Toxicol Lett. 1995 May;77(1-3):213–217. doi: 10.1016/0378-4274(95)03295-9. [DOI] [PubMed] [Google Scholar]
  14. Schulte P. A. A conceptual framework for the validation and use of biologic markers. Environ Res. 1989 Apr;48(2):129–144. doi: 10.1016/s0013-9351(89)80029-5. [DOI] [PubMed] [Google Scholar]
  15. Woollen B. H., Marsh J. R., Laird W. J., Lesser J. E. The metabolism of cypermethrin in man: differences in urinary metabolite profiles following oral and dermal administration. Xenobiotica. 1992 Aug;22(8):983–991. doi: 10.3109/00498259209049904. [DOI] [PubMed] [Google Scholar]
  16. Zielhuis R. L., Henderson P. T. Definitions of monitoring activities and their relevance for the practice of occupational health. Int Arch Occup Environ Health. 1986;57(4):249–257. doi: 10.1007/BF00406181. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES